These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 13726313)

  • 1. [Use of complexons in medicine].
    ELBOWICZ-WANIEWSKA Z
    Pol Tyg Lek; 1961 Apr; 16():646-50. PubMed ID: 13726313
    [No Abstract]   [Full Text] [Related]  

  • 2. 2 cases of scleroderma treated by chelators.
    DEPONDT M; FLAMANT R; ROY L
    Gaz Med Fr; 1961 Feb; 68():459-62. PubMed ID: 13721997
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of hemochromatosis].
    WOEHLER F
    Med Klin; 1962 Aug; 57():1370-6. PubMed ID: 14007830
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chelating agents in occupational pathology].
    MICHAUX P
    Alger Medicale; 1961 Oct; 65():789-802. PubMed ID: 14473389
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of complexons in clinico-laboratory practice].
    BABACHEV GN; KOL'KOVSKII PG
    Vopr Med Khim; 1960; 6():541-3. PubMed ID: 13685507
    [No Abstract]   [Full Text] [Related]  

  • 6. Design of chelates for therapeutic objectives.
    RUBIN M
    Fed Proc; 1961 Sep; 20(3)Pt 2():149-56. PubMed ID: 14494918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-cyanide properties of cobalt chelates].
    MARKICEVIC A
    Lijec Vjesn; 1962 Jun; 84():586-8. PubMed ID: 14469977
    [No Abstract]   [Full Text] [Related]  

  • 8. [Introductory recollections on cellular and extracellular ionic balance, and changes brought about by chelating substances; preliminary notes on the use and the indications of said substances in cardiovascular pathology].
    MACCARINI PA
    Clin Ter; 1962 Jan; 22():126-32. PubMed ID: 14467754
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential uses of chelation methods in the treatment of cardiovascular diseases.
    KITCHELL JR; MELTZER LE; SEVEN MJ
    Prog Cardiovasc Dis; 1961 Jan; 3():338-49. PubMed ID: 13756462
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary note on the therapeutic use of flavonic magnesium chelates in mental disorders of senescence. Pharmacodynamic and experimental data].
    BERNARD P; NOEL P; BLES G
    Rev Fr Gerontol; 1962 Apr; 8():179-82. PubMed ID: 13868049
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of bicarbonate and its combination with chelating agents used for the removal of depleted uranium in rats.
    Fukuda S; Ikeda M; Nakamura M; Katoh A; Yan X; Xie Y; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):191-8. PubMed ID: 18274996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EDTA chelation therapy meets evidence-based medicine.
    Lamas GA; Hussein SJ
    Complement Ther Clin Pract; 2006 Aug; 12(3):213-5. PubMed ID: 16835033
    [No Abstract]   [Full Text] [Related]  

  • 13. Heavy metal stabilization in municipal solid waste incineration flyash using heavy metal chelating agents.
    Jianguo J; Jun W; Xin X; Wei W; Zhou D; Yan Z
    J Hazard Mater; 2004 Sep; 113(1-3):141-6. PubMed ID: 15363524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
    Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
    Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of various chelating agents on supercritical carbon dioxide extraction of indium(III) ions from acidic aqueous solution.
    Chou WL; Yang KC
    J Hazard Mater; 2008 Jun; 154(1-3):498-505. PubMed ID: 18054158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and metal complexation properties of Ph-DTPA and Ph-TTHA: novel radionuclide chelating agents for use in nuclear medicine.
    Gouin SG; Gestin JF; Monrandeau L; Segat-Dioury F; Meslin JC; Deniaud D
    Org Biomol Chem; 2005 Feb; 3(3):454-61. PubMed ID: 15678183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE ROLE OF CHELATING AGENTS IN SPECTROPHOTOMETRIC ANALYSIS.
    BOLTZ DF
    Rec Chem Prog; 1963 Sep; 24():167-78. PubMed ID: 14062260
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of chelating agents on the behavior of lead in the body].
    CATSCH A
    Arzneimittelforschung; 1962 Sep; 12():924-30. PubMed ID: 14019358
    [No Abstract]   [Full Text] [Related]  

  • 19. Chelating agents and the environment.
    Nowack B
    Environ Pollut; 2008 May; 153(1):1-2. PubMed ID: 18336972
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of siderosis by desferrioxamine B. Comparison with the action of 2 other chelating agents].
    ALBAHARY C; RENAULT J; LABARBE P; GIRAUD J
    Presse Med (1893); 1962 Dec; 70():2823-6. PubMed ID: 14011640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.